Change in Pd/Pa: Clinical Implications for Predicting Future Cardiac Events at Deferred Coronary Lesions

Kota Murai Yu Kataoka Eri Kiyoshige Takamasa Iwai Kenichiro Sawada Hideo Matama Hiroyuki Miura Satoshi Honda Masashi Fujino Shuichi Yoneda Kazuhiro Nakao Kensuke Takagi Fumiyuki Otsuka Yasuhide Asaumi Kunihiro Nishimura Teruo Noguchi Department of Cardiovascular Medicine,National Cerebral and Cardiovascular Center,Suita,Osaka,Japan Department of Preventive Medicine and Epidemiology,National Cerebral and Cardiovascular Center,Suita,Osaka,Japan

DOI: https://doi.org/10.1161/circinterventions.124.013830

2024-07-27

Circulation Cardiovascular Interventions

Abstract:Circulation: Cardiovascular Interventions, Ahead of Print. Background:Cardiovascular events still occur at intermediate stenosis with fractional flow reserve (FFR) ≥0.81, underscoring the additional measure to evaluate this residual risk. A reduction in distal coronary artery pressure/aortic pressure from baseline to hyperemia (i.e., change in Pd/Pa) reflects lipidic burden within vessel walls. We hypothesized that this physiological measure might stratify the risk of future cardiac events at deferrable lesions.Methods:Lesion- (899 intermediate lesions) and patient-based (899 deferred patients) analyses in those with FFR ≥0.81 were conducted to investigate the association between change in Pd/Pa and target lesion failure (TLF) and major adverse cardiac events (MACE) at 7 years, respectively.Results:The occurrence of TLF and MACE was 6.7% and 13.4%, respectively. The incidence of target lesion-related non-fatal myocardial infarction was 0.6%. Lesions with TLF had greater change in Pd/Pa (0.11±0.03 vs. 0.09±0.04; P=0.002), larger diameter stenosis (51.0±9.2% vs. 46.4±12.4%; P=0.048), and smaller FFR (0.84 (0.82–0.87) vs. 0.86 (0.83–0.90); P=0.02). Change in Pd/Pa (per 0.01 increase) predicted TLF (odds ratio, 1.16; 95% confidence interval (CI), 1.05–1.28; P=0.002) and MACE (odds ratio, 1.08; 95% CI, 1.01–1.16; P=0.03). Lesions with change in Pd/Pa ≥0.10 had 2.94- and 1.85-fold greater likelihood of TLF (95% CI, 1.30–6.69; P=0.01) and MACE (95% CI, 1.08–3.17; P=0.03), respectively. Lesions with FFR ≤0.85 had substantially higher likelihood of TLF when change in Pd/Pa ≥0.10 (12.4% vs. 2.9%; hazard ratio, 3.60, 95% CI, 1.01–12.80; P=0.04). However, change in Pd/Pa did not affect TLF risk in lesions with FFR ≥0.86 (3.8% vs. 3.7%; hazard ratio, 0.56; 95% CI, 0.06–5.62; P=0.62).Conclusions:Despite deferrable FFR values, lesions and patients with change in Pd/Pa ≥0.10 had higher cardiovascular risk. Change in Pd/Pa might help stratify lesion- and patient-level risk of future cardiac events in those with FFR ≥0.81.

cardiac & cardiovascular systems